Media Contact

social-linkedin social-youtube  social-facebook  social-twitter  social-instagram

LabMind podcasts

View Factsheet PDF

Illustration of Lone star tick surrounded by antibodies in the bloodstream.

When a lone star tick bites a person, it can transfer alpha-gal into the person’s bloodstream, leading to the development of anti-alpha-gal antibodies. These antibodies can trigger an allergic reaction to red meat, or according to a new study, a reaction to a blood transfusion in some patients.

August 24, 2026

Study in Which ARUP Played a Role Identifies New Transfusion Risk Linked to Alpha-Gal Syndrome

A newly published epidemiologic study provides evidence for a previously unrecognized transfusion risk for patients with alpha-gal syndrome, an allergic condition that can develop after a tick bite.

Dr. Jonathan Genzen stands in front of an officce window.

Jonathan Genzen, MD, PhD, MBA, ARUP chief medical officer and senior director of government affairs, explores key provisions of the Enhancing CLIA Act in a seven-part article series on LinkedIn to help inform the discussion around future oversight of laboratory-developed tests.

August 20, 2026

Jonathan Genzen, MD, PhD, MBA, ARUP CMO, Explores Lab-Developed Test Oversight in Article Series

The seven-part article series explores key provisions of the Enhancing CLIA Act and is intended to encourage thoughtful discussions about the future of regulating laboratory-developed tests.

Text text text

Attendees will have the unique opportunity to tour ARUP Laboratories during the 2026 AMLI Annual Meeting.

August 4, 2026

ARUP Experts To Present on Emerging Immunology Topics at the 2026 AMLI Annual Meeting

ARUP pairs analytical rigor with specialty expertise in immunopathology to provide reliable results, insights, and answers to complex diagnostic questions. Explore solutions with us at AMLI 2026.

Screenshot of dashboard that shows the Cyclospora positivity rates

ARUP Laboratories observed Cyclospora positivity rates increase from very low levels to unprecedented levels within a short period of time, highlighting the importance of providing clinicians and laboratorians with timely disease surveillance data, said Ben Bradley, MD, PhD, ARUP head of clinical operations for Infectious Disease.

August 3, 2026

ARUP Laboratories Adds Cyclospora Data to Infectious Disease Dashboard Amid National Outbreak

ARUP Laboratories’ Infectious Disease Test Positivity Trends Dashboard now includes Cyclospora data to help clinicians and public health professionals monitor the rising cyclosporiasis outbreak.

Image of small neoplastic populations

ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes small neoplastic populations with greater sensitivity than conventional flow cytometry while requiring less specimen volume.

July 20, 2026

ARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple Myeloma

ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes neoplastic populations with greater confidence and sensitivity, while minimizing specimen volume requirements.

Join ARUP at ADLM 2026 Booth 4453

Visit ARUP at booth #4453 to learn more about what’s happening at the forefront of laboratory medicine, speak with our experts, and test your skills at parasite and blood cell identification.

July 16, 2026

ARUP Heads to ADLM 2026 With New Research and Innovative Developments in Laboratory Medicine

Discover how ARUP is advancing laboratory medicine at ADLM 2026 through research presentations, expert insights, and innovative diagnostic solutions.

Media Contact

social-linkedin social-youtube  social-facebook  social-twitter  social-instagram